Most Recent Additions*
Prevalence of Molecular Alterations in Fine Needle Aspirations of Follicular Neoplasms: An Institutional Experience
Clare F Hartman
Improving Emergency Department Care for Sexual Assault Patients: A 2-Part Quality Improvement Study
Jennifer Broza
Impact of autoimmune disease on outcomes after BCMA-directed CAR-T cell therapy for patients with multiple myeloma
Rebecca Albuquerque
Treatment related outcomes of very old (>85 years) diffuse large b-cell lymphoma patients.
Jonathan J Zhao
Applicant Interview Metrics and Preference Signaling in Dermatology: A Serial Cross-Sectional Study.
Elizabeth Botto, Laurie A Temiz, Alison Kucharik, and Nishit Patel
Pediatric Dermatology Learning Needs Identified Through Continuing Certification Program Assessments of the American Board of Dermatology.
Erik J Stratman, Julie V Schaffer, Stanley J Miller, Anna L Bruckner, Mercedes E Gonzalez, Andrea L Zaenglein, and Randall K Roenigk
Chromatin Disruption After Prenatal Hypoxia Predicts Lasting Neuron Deficits.
Ana G Cristancho, Donald J Joseph, Margaret M Cassidy, Preeti S Chauhan, Ethan J Gadra, Elyse C Gadra, Donya Zarrinnegar, Bianca N Rodriguez, and Eric D Marsh
Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis.
Jonathan I Silverberg, Emma Guttman-Yassky, Diamant Thaçi, Alan D Irvine, Linda Stein Gold, Andrew Blauvelt, Eric L Simpson, Chia-Yu Chu, Zhuqing Liu, Renata Gontijo Lima, Sreekumar G Pillai, Julien Seneschal, ADvocate1 and ADvocate2 Investigators, and Stephen Schleicher MD
Lack of effect of benralizumab on signs and symptoms of moderate-to-severe atopic dermatitis: Results from the phase 2 randomized, double-blind, placebo-controlled HILLIER trial.
E Guttman-Yassky, L Bahadori, L Brooks, K L Clark, H Grindebacke, C N Ho, R Katial, T-H Pham, C Walton, C J Datto, HILLIER study group, and Stephen Schleicher MD
Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials.
Christopher E M Griffiths, Kristian Reich, Mark Lebwohl, Peter van de Kerkhof, Carle Paul, Alan Menter, Gregory S Cameron, Janelle Erickson, Lu Zhang, Roberta J Secrest, Susan Ball, Daniel K Braun, Olawale O Osuntokun, Michael P Heffernan, Brian J Nickoloff, Kim Papp, UNCOVER-2 and UNCOVER-3 investigators, and Stephen Schleicher MD
Adapalene 0.1% lotion in the treatment of acne vulgaris: results from two placebo-controlled, multicenter, randomized double-blind, clinical studies.
Lawrence F Eichenfield, Michael Jarratt, Joel Schlessinger, Steven Kempers, Vasant Manna, Joyce Hwa, Yin Liu, Michael Graeber, Adapalene Lotion Study Group, and Stephen Schleicher MD
Classification of Oncologic Drugs and their Potential Renal Adverse Events: suspicion, diagnosis and management
Julien Sanon MD
A UNIQUE PATIENT: COMBINING PROSTHETIC TRAINING WITH NEUROREHABILITATION IN PHOCOMELIA
Bruce Zhang MD
SCAPULAR WINGING CAUSED BY PROXIMAL UPPER TRUNK BRACHIAL PLEXOPATHY IN COMBAT SPORTS: A CASE REPORT
Bruce Zhang MD
*Updated as of 12/17/25.